Evidence map›Paper›PMID 24788409›Full record

ArticleThe EMBO journal2014

c-Src drives intestinal regeneration and transformation.

Julia B Cordero, Rachel A Ridgway, Nicola Valeri, Colin Nixon, Margaret C Frame, William J Muller, Marcos Vidal, Owen J Sansom

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Progastrin Promotes Colorectal Cancer Stem Cell-Like Properties via the Receptor PZR.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Nutrient Sensing via Gut inInternational journal of molecular sciences · 2022
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Julia B CorderoThe Beatson Institute for Cancer Research, Bearsden Glasgow, UK.
Rachel A RidgwayThe Beatson Institute for Cancer Research, Bearsden Glasgow, UK.
Nicola ValeriInstitute of Cancer Research, Sutton London, UK.
Colin NixonThe Beatson Institute for Cancer Research, Bearsden Glasgow, UK.
Margaret C FrameEdinburgh Cancer Research Centre Institute of Genetics & Molecular Medicine University of Edinburgh, Edinburgh, UK.
William J MullerGoodman Cancer Research Center McGill University, Montreal, QC, Canada.
Marcos VidalThe Beatson Institute for Cancer Research, Bearsden Glasgow, UK.
Owen J SansomThe Beatson Institute for Cancer Research, Bearsden Glasgow, UK o.sansom@beatson.gla.ac.uk.
Cancer Research UK Scotland Institute · GBEdinburgh Cancer Research · GBInstitute of Cancer Research · GBMcGill University · CA

Funding

Cancer Research UK 12481Cancer Research UK 15703Cancer Research UK 18052National Centre for the Replacement, Refinement and Reduction of Animals in Research G1000078/1
6 · The paper itself

Abstract

The non-receptor tyrosine kinase c-Src, hereafter referred to as Src, is overexpressed or activated in multiple human malignancies. There has been much speculation about the functional role of Src in colorectal cancer (CRC), with Src amplification and potential activating mutations in up to 20% of the human tumours, although this has never been addressed due to multiple redundant family members. Here, we have used the adult Drosophila and mouse intestinal epithelium as paradigms to define a role for Src during tissue homeostasis, damage-induced regeneration and hyperplasia. Through genetic gain and loss of function experiments, we demonstrate that Src is necessary and sufficient to drive intestinal stem cell (ISC) proliferation during tissue self-renewal, regeneration and tumourigenesis. Surprisingly, Src plays a non-redundant role in the mouse intestine, which cannot be substituted by the other family kinases Fyn and Yes. Mechanistically, we show that Src drives ISC proliferation through upregulation of EGFR and activation of Ras/MAPK and Stat3 signalling. Therefore, we demonstrate a novel essential role for Src in intestinal stem/progenitor cell proliferation and tumourigenesis initiation in vivo.

Indexed as

RegenerationAnimalsCell ProliferationCell Transformation, NeoplasticColorectal NeoplasmsCSK Tyrosine-Protein KinaseDrosophila melanogasterDrosophila ProteinsErbB ReceptorsGene AmplificationHumansIntestinal MucosaMAP Kinase Signaling SystemMiceMice, TransgenicProtein-Tyrosine KinasesCsk protein, DrosophilaCSK protein, humanCSK Tyrosine-Protein KinaseDrosophila ProteinsEgfr protein, DrosophilaEGFR protein, mouseErbB ReceptorsProtein-Tyrosine KinasesProto-Oncogene ProteinsReceptors, Invertebrate PeptideSrc64B protein, Drosophilasrc-Family KinasesStat3 protein, mouseSTAT3 Transcription FactorApcintestinal stem cellsregenerationSrctumourigenesis

Identifiers

PMID24788409
PMCPMC4194090
OpenAlexW2021181797

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.